Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

More Baby Food: CABIO Biotech is Hungry for Public Capital
More Baby Food: CABIO Biotech is Hungry for Public Capital
Milk in pitcher and drinking glass. Image credit: Pixabay.
Associated Company
EqualOcean EqualOcean

The STAR Market, a new Shanghai Stock Exchange-based venue, is aimed at giving local hi-tech companies a broader access to multiple sources in order to fund their businesses. It was launched a month ago and is expected to start trading on July 22 with the first batch of 25 companies debuting on the board.

CABIO Biotech (Wuhan) Co., Ltd. (嘉必优) is a leading food manufacturer specializing in arachidonic acids, algal oils, carotenes and other products. The company filed for an initial public offering on the STAR board on April 29. It is the only firm representing food industry among the 148 applicants, as of today.

Worth mentioning that the firm has already submitted an application for an IPO in China: two years earlier it made an attempt to get listed on the Shenzhen Stock Exchange-based Nasdaq-style ChiNext board. At that time, CABIO didn’t pass the approval process due to a handful of reasons including price discrimination. 

CABIO’s Wuhan factories are concentrated around production of DHA (docosahexaenoic acid) and ARA (arachidonic acid), synthesized versions of the essential fatty acids that are naturally found in breast milk. Those are the key components of various infant formula produced around the world.

The firm generated operating revenue of CNY 286 million (USD 41.6 million) last year, the indicator soared 25% from 2017’ record. Gross profit margin had raised from 46.45% to 48.94% over the same period.

According to an online provider of market and consumer data Statista, baby food market size in China amounted to CNY 17 billion (USD 2.5 billion) last year. The market is expected to grow annually by 4.2% and reach CNY 21.5 billion (USD 3.12 billion) in 2023.

Enterprise Information

EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Enterprise Information

EqualOcean
EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is a leading industrial tech media and investment research company that focuses on technological and industrial innovation in China.

We aim to assist Chinese entrepreneurial enterprises to break into the global market and provide overseas investors, VCs, and enterprises with a deeper understanding of China's business environment and to seize opportunities in China.

Join over 800,000 of your peers